<?xml version='1.0' encoding='utf-8'?>
<document id="30132394"><sentence text="Comparison of uptake transporter functions in hepatocytes in different species to determine the optimal model for evaluating drug transporter activities in humans." /><sentence text="A thorough understanding of species-dependent differences in hepatic uptake transporters is critical for predicting human pharmacokinetics (PKs) from preclinical data" /><sentence text=" In this study, the activities of organic anion transporting polypeptide (OATP/Oatp), organic cation transporter 1 (OCT1/Oct1), and sodium-taurocholate cotransporting polypeptide (NTCP/Ntcp) in cultured rat, dog, monkey and human hepatocytes were compared" /><sentence text=" The activities of hepatic uptake transporters were evaluated with respect to culture duration, substrate and species-dependent differences in hepatocytes" /><sentence text=" Longer culture duration reduced hepatic uptake transporter activities across species except for Oatp and Ntcp in rats" /><sentence text=" Comparable apparent Michaelis-Menten constant (Km,app) values in hepatocytes were observed across species for atorvastatin, estradiol-17β-glucuronide and metformin"><entity charOffset="111-123" id="DDI-PubMed.30132394.s6.e0" text="atorvastatin" /><entity charOffset="125-150" id="DDI-PubMed.30132394.s6.e1" text="estradiol-17β-glucuronide" /><entity charOffset="155-164" id="DDI-PubMed.30132394.s6.e2" text="metformin" /><pair ddi="false" e1="DDI-PubMed.30132394.s6.e0" e2="DDI-PubMed.30132394.s6.e0" /><pair ddi="false" e1="DDI-PubMed.30132394.s6.e0" e2="DDI-PubMed.30132394.s6.e1" /><pair ddi="false" e1="DDI-PubMed.30132394.s6.e0" e2="DDI-PubMed.30132394.s6.e2" /><pair ddi="false" e1="DDI-PubMed.30132394.s6.e1" e2="DDI-PubMed.30132394.s6.e1" /><pair ddi="false" e1="DDI-PubMed.30132394.s6.e1" e2="DDI-PubMed.30132394.s6.e2" /></sentence><sentence text=" The Km,app values for rosuvastatin and taurocholate were significantly different across species"><entity charOffset="23-35" id="DDI-PubMed.30132394.s7.e0" text="rosuvastatin" /><entity charOffset="40-52" id="DDI-PubMed.30132394.s7.e1" text="taurocholate" /><pair ddi="false" e1="DDI-PubMed.30132394.s7.e0" e2="DDI-PubMed.30132394.s7.e0" /><pair ddi="false" e1="DDI-PubMed.30132394.s7.e0" e2="DDI-PubMed.30132394.s7.e1" /></sentence><sentence text=" Rat hepatocytes exhibited the highest Oatp percentage of uptake transporter-mediated permeation clearance (PSinf,act) while no difference in %PSinf,act of probe substrates were observed across species" /><sentence text=" The in vitro hepatocyte inhibition data in rats, monkeys and humans provided reasonable predictions of in vivo drug-drug interaction (DDIs) between atorvastatin/rosuvastatin and rifampin"><entity charOffset="149-161" id="DDI-PubMed.30132394.s9.e0" text="atorvastatin" /><entity charOffset="162-174" id="DDI-PubMed.30132394.s9.e1" text="rosuvastatin" /><entity charOffset="179-187" id="DDI-PubMed.30132394.s9.e2" text="rifampin" /><pair ddi="false" e1="DDI-PubMed.30132394.s9.e0" e2="DDI-PubMed.30132394.s9.e0" /><pair ddi="false" e1="DDI-PubMed.30132394.s9.e0" e2="DDI-PubMed.30132394.s9.e1" /><pair ddi="false" e1="DDI-PubMed.30132394.s9.e0" e2="DDI-PubMed.30132394.s9.e2" /><pair ddi="false" e1="DDI-PubMed.30132394.s9.e1" e2="DDI-PubMed.30132394.s9.e1" /><pair ddi="false" e1="DDI-PubMed.30132394.s9.e1" e2="DDI-PubMed.30132394.s9.e2" /></sentence><sentence text=" These findings suggested that using human hepatocytes with a short culture time is the most robust preclinical model for predicting DDIs for compounds exhibiting active hepatic uptake in humans" /><sentence text="" /></document>